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Abstract
Hypoxia is a severe stressful condition and induces cell death leading to neuronal loss both to the developing and adult
nervous system. Central theme to cellular death is the activation of different classes of proteases such as caspases calpains
and cathepsins. In the present study we investigated the involvement of these proteases, in the hypoxia-induced PC12 cell
death. Rat PC12 is a model cell line for experimentation relevant to the nervous system and several protocols have been
developed for either lethal hypoxia (oxygen and glucose deprivation OGD) or ischemic preconditioning (IPS). Nerve Growth
Factor (NGF) treated PC12 differentiate to a sympathetic phenotype, expressing neurites and excitability. Lethal hypoxia was
established by exposing undifferentiated and NGF-treated PC12 cells to a mixture of N2/CO2 (93:5%) in DMEM depleted of
glucose and sodium pyruvate for 16 h. The involvement of caspases, calpains and lysosomal cathepsins D and E to the cell
death induced by lethal OGD was investigated employing protease specific inhibitors such as z-VAD-fmk for the caspases,
MDL28170 for the calpains and pepstatin A for the cathepsins D and E. Our findings show that pepstatin A provides
statistically significant protection from cell death of both naive and NGF treated PC12 cells exposed to lethal OGD. We
propose that apart from the established processes of apoptosis and necrosis that are integral components of lethal OGD,
the activation of cathepsins D and E launches additional cell death pathways in which these proteases are key partners.
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Introduction
Reduced oxygen supply to the brain causes severe adverse
effects such as neurological handicaps due to neuronal cell death
from energy shortage, free radicals damage, glutamate induced
excitotoxicity, and launches numerous diverse cell survival and
death mechanisms. Several in-vitro and in-vivo models have been
developed to study conditions that approximate ischemia to the
brain. A widely accepted model of ischemia has been developed
using PC12 cells exposed in conditions of oxygen and glucose
deprivation (OGD). PC12 cells originating from rat pheochromo-
cytoma upon Nerve Growth Factor (NGF) treatment, switch their
phenotype from a proliferating, undifferentiated cell to a post-
mitotic, differentiated, neurite-bearing NGF-dependent neuron
[1]. OGD exposed PC12 cells reportedly suffer from mitochon-
drial dysfunction, oxidative stress and loss of energy that eventually
lead to cell death [2–4]. This cell death in some cases is
characterised as apoptotic [5,6] in others as necrotic [7] and in
some recent reports, the process of autophagy is implicated in the
cell death processes [8,9]. This situation is also reflected in hypoxic
rat brain studies stating that ‘‘early neurodegeneration after
hypoxia-ischemia in neonatal rat is necrosis while delayed
neuronal death is apoptosis’’ [10]. In some cases a ‘‘continuum
phenotype’’ of cell death is reported [11] when apoptosis is
hindered from completion possibly due to energy shortage. There
are early reports indicating that in ischemia, the activation of the
family of cysteine proteases, caspases, is upregulated [12].
On the other hand the abnormal increase of the intracellular
Ca
2+ levels triggers the neuronal damage associated with hypoxia
or ischemia. In the vulnerable neurons the endogenous Ca
2+ levels
can be abnormally increased via several routes, resulting in the
activation of a number of calcium-sensitive enzymes such as the
family of calpain proteases [13–15].
Several lines of evidence suggest that calcium-activated proteol-
ysis plays a pivotal role in hypoxic-ischemic neuronal damage. The
levels of spectrin, microtubule-associated protein and neurofilament
protein, are substantially reduced during and after dense hypoxia or
ischemia. These proteins are preferred substrates for the calcium-
activated proteases, calpains [16,17]. Indeed, calpain-mediated
proteolysis appears to be one of the earliest biochemical changes
occurring after a dense ischemic challenge [18].
While caspases are the key partners for eliciting apoptotic cell
death [19,20], calpains are considered to participate in necrotic
cell death [21,22]. Furthermore a third class of proteases, the
lysosomal cathepsins, has a dual role in regulating apoptosis [23–
25], and executing necrosis [26]. Moreover, the lysosomal
cathepsins are constituent members of the autophagic pathways
[26,27].
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8In the present study we have investigated in detail the roles
played by the calpains, caspases and the lysosomal cathepsins, in
our PC12-OGD model for lethal hypoxia, by specific inhibition of
their activities.
Results
Lethal Hypoxia
PC12 cells were exposed in lethal hypoxia conditions (OGD for
16 hours) as described by [8,28]. The number of cells survived
OGD was initially determined by trypan blue exclusion assay and
cell counting on a Neubauer plate (data not shown). After having
established that death was due to hypoxia, cell viability was
determined by assessment of the integrity of mitochondrial function
using the MTT assay. PC12 cells exposed to OGD show a
statistically significant reduction in the number of living cells, down
to 25.1%618.3%, p,0.001, compared to PC12 cells growing in
complete medium under normoxia (control population 100%), as
determined by the MTT assay Figures 1a, 2a, 3a, 4a, 5a.
Similarly NGF treated PC12 cells exposed to OGD showed a
statistically significant reduction in the number of living cells down
to 31.6%622.8, (p,0.001significance) compared to NGF differen-
tiated PC12 cells growing in complete medium under normoxia
(control population 100%). Figure 1b, 2b, 3b, 4b, 5b.
Caspases’ inhibition
To assess the involvement of the caspases in the cell death caused
by lethal hypoxia we exposed naı ¨ve and NGF treated PC12 cells to
OGD conditions after a 30 min preincubation with different
concentrations of the specific caspase inhibitor z-VAD-fmk.
Remarkably, the z-VAD-fmk caspase inhibition in a concentration
of 10 mM, significantly protects untreated PC12 cells from lethal
hypoxia (60.7%617.4 cell survival compared to PC12 cells growing
in normoxia used as control (p,0.05). Figure 1a.
On the other hand lethal hypoxia reduced the cell population of
NGF treated cells down to 31.6%622.8 at p,0.001 significance
(compared to the control cells). Perincubation with 10 mM z-VAD-
fmk increased the survival of the cells to 83.1%621.7, p,0.05
significance. In contrast, the use of a higher concentration of the z-
VAD-fmk inhibitor (50 mM) was not effective in increasing cell
viability in this assay Figure 1b.
Calpains’ Inhibition
Next we investigated the calpains involvement in the cell death
elicited by lethal OGD. To this end, we have treated naı ¨ve and
NGF differentiated PC12 cells with different concentrations of the
specific calpain inhibitor MDL28170 for 30 min before subjecting
them to OGD. The pre-treatment of undifferentiated PC12 cells
with 10 mM of MDL18170 results in increased cell viability
Figure 1. Effect of 16 hours Oxygen-Glucose Deprivation (OGD) on % survival of PC12 cells in the absence or presence of 10 mM
and 50 mM of the specific caspase inhibitor z-VAD-fmk. The values are presented as mean 6 SEM, *p,0.05, **p,0.01. Panel a, naive PC12
cells, panel b PC12 cells NGF treated.
doi:10.1371/journal.pone.0025950.g001
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significant protection of the treated PC12 cell population against
OGD, compared to the control cells. In contrast, cell pre-
treatment with higher amounts of MDL18170 (50 mM and
100 mM) failed to provide significant statistical protection of the
treated cells against OGD (Figure 2a).
Similarly, 10 mM but not 50 mM or 100 mM of the MDL18170
inhibitor, protected from OGD induced cell death the NGF
differentiated PC12 cells (70.4%622.3, p,0.05 significance)
compared to untreated control cells Figure 2b.
Cathepsins’ Inhibition
Pepstatin A which is an aspartyl protease inhibitor, specific for
cathepsins D and E, was used to assess the role of these proteases
in OGD induced cell death. Preincubation of both naı ¨ve and NGF
treated PC12 cells with 5 mM of pepstatin A increased the viability
of the naı ¨ve and the NGF treated cell population to 93.16%625.2
and 94.4%619.8 both at a statistical significance of p,0.01
respectively compared to the control cells (Figure 4a and
Figure 4b) and protected both cell populations from lethal OGD.
Combination of protease inhibitors
We next tested whether the combined use of different protease
inhibitors results in increased survival of OGD subjected naı ¨ve
PC12 cells. A statistically significant survival increase of the lethal
OGD exposed PC12 cell was observed in the situation were a)
10 mM z-VAD-fmk in addition to 10 mM MDL28170 were used;
we observed 54.8615% survival at p,0.05 significance of the
treated cells compared to control cell population, b) 10 mMz -
VAD-fmk in addition to 5 mM Pepstatin A were used; we observed
a 84.1616.3% survival, at p,0.05 significance and c) 10 mM
MDL28170 together with 5 mM Pepstatin A were used; we
observed a 91.25614.3% survival at p,0.05 significance
(Figure 4a).
Additionally, similar results were obtained with NGF differen-
tiated PC12 cell populations preincubated with combinations of
the protease inhibitors. Specifically, a) the combined addition of
10 mM z-VAD-fmk and 10 mM MDL28170 resulted in
60.6617.4% cell viability (at p,0.05 significance), b) the
combined addition of 10 mM z-VAD-fmk and 5 mM Pepstatin A
resulted in 87.8%621.3% survival (at p,0.05 significance) and c)
10 mM MDL28170 in addition to 5 mM Pepstatin A raised the
living cell number to 77.5619.1% (at p,0.05 significance)
Figure 4b.
Remarkably, the combination of all three inhibitors, at the
effective concentrations, was marginally effective in improving the
survival of either naı ¨ve or NGF treated PC12 cells exposed to
lethal OGD; we observed a 69.7%617.2 survival at p=0.051 for
Figure 2. Effect of 16 hours Oxygen-Glucose Deprivation (OGD) on % survival of PC12 cells in the absence or presence of the
permeable calpain inhibitor MDL28170 (10 mM, 50 mM and 100 mM). The values are presented as mean 6 SEM, *p,0.05, **p,0.01,
***p,0,001. Panel a, naive PC12 cells, panel b PC12 cells NGF treated.
doi:10.1371/journal.pone.0025950.g002
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p,0.05 significance) for NGF treated PC12 (Figure 4b). In either
case, the post hoc analysis did not reveal any statistical differences
when comparing with the combinations of two inhibitors.
Flow Cytometry
Naive PC12 Cells. Analysis of the results obtained from
Annexin V–FITC/PI cell membrane integrity and permeability
assay in PC12 cells revealed that under normoxia 85.965% of the
cell population was alive, 10.464% was found to be in an
apoptotic stage and 3.663% was already dead. These numbers
were expressed as percentage of the living cells; 12.2% were in an
apoptotic state and 4.2% were dead. After 16 hours of OGD these
percentages were 240.2% apoptotic and 268.6% dead (expressed
as percent of the living cells in each state i.e. apoptotic or dead).
Figure 5 PC12 preincubated with either 10 mM z-VAD-fmk or
10 mM MDL28170 alone or in combination, show a statically
insignificant decrease of both the apoptotic and the dead cell
populations percentages Figures 5a, b, c.
In contrast, the preincubation with 5 mM Pepstatin A,
Figure 5d, decreased the apoptotic and dead cell populations
of naive PC12 cell exposed to lethal hypoxia measured by this
assay to 18.7% and 68.2% respectively in a statistically significant
manner, compared to the OGD subjected control cell population
(p,0.001).
Preincubation of PC12 cells with 5 mM Pepstatin A in double
combinations with the other inhibitors as well as with the
combination containing all three inhibitors annul the OGD effect
in the alive and apoptotic cell populations in a statistically
significant manner. More specifically, the numbers representing
the percent of the living cells in each state (apoptotic or dead) were
23.4% apoptotic and 71.8% dead when used in double
combination with z-VAD-fmk 10 mM( p ,0.001), or 16.7%
apoptotic and 68.5% dead when used in double combination
with MDL28170 10 mM( p ,0.001) or 17.9% apoptotic and
60.7% dead when the triple combination with all inhibitors
(p,0.001) expressed as percent of the living cells in each state
(apoptotic or dead) ) Figures 5e, f, g.
NGF treated cells
Annexin V–FITC/PI staining coupled with flow cytometry
assay of NGF treated cells showed that under normal conditions
87.2% of the total cell population were alive, 9.2% were
apparently early apoptotic as they were Annexin V positive and
3.6% were dead cells (PI positive). The same result expressed as
the percentage of the living cells is 10.6% of the living cell
population were early apoptotic and 4.1% dead.
16 hours OGD exposed NGF treated PC12 cells, were found to
be 266.6% apoptotic and 377.1% dead, expressed as percent of
the living cell population Figure 6. Preincubation with either
Figure 3. Effect of 16 hours Oxygen-Glucose Deprivation (OGD) on % survival of PC12 cells in the absence or presence of different
concentrations of the aspartyl protease inhibitor pepstatin A (1 mM and 5 mM). The values are presented as mean 6 SEM, *p,0.05,
**p,0.01. Panel a, naive PC12 cells, panel b PC12 cells NGF treated.
doi:10.1371/journal.pone.0025950.g003
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tion decreased slightly the numbers of both the apoptotic and dead
cells but this reduction was not statistically significant Figures 6
a, b and c. In sharp contrast, preincubation with 5 mM pepstatin
either alone or in combination with the other inhibitors was
sufficient to protect NGF treated PC12 cells from lethal hypoxia in
a statistical significant manner. 5 mM pepstatin treatment alone
reduced the apoptotic and dead cell percentages to 27.8% and
85.3% respectively (p,0.001) Figure 6d.5 mM pepstatin in
combination with z-10 mM VAD-fmk treatment reduced the
apoptotic and dead cell percentages to 31.9% apoptotic and
23.4%respectively (p,0.001) and 5 mM pepstatin in combination
with 10 mM MDL28170 reduced the cell percentages to 21.7%
apoptotic and 30.7% dead (p,0.001). When the triple inhibitors
combination treatment was employed, the percentages were as
follows: 28.1% apoptotic and 41.2% dead (p,0.001) Figure 6 e,
f, and g.
Discussion
In this work we investigated the involvement of different classes
of proteases in the cell death elicited by OGD on naive and NGF
treated PC12 cells. In the past, there were reports implicating
NGF in the way PC12 cells respond under hypoxic conditions or
that NGF exerts a neuroprotective role in a PC12 in vitro OGD
model [29,30], therefore we felt it would be important to extend
our experimentation on NFG treated PC12 cells in our OGD
model and test the consistency of our observations in the two
different developmental stages of the PC12 cells. We have
preincubated the cells with specific protease inhibitors and we
subsequently exposed them to OGD in order to assess the
involvement of the different protease classes to the OGD induced
cell death. Cell death or survival was assessed by the two different
assays; the MTT assay measuring the integrity of mitochondrial
function and by Annexin V-FITC and PI staining coupled by flow
cytometry measuring the integrity of the cell membranes. Trypan
blue exclusion assay was used to monitor cell death routinely since
there are reports showing that at least in some cases results
obtained for cell viability differ significantly depending on the
method used [31]. Both trypan blue and MTT assays detected cell
death efficiently and the results of both assays were consistent to
one another. Our data is in agreement with other reports
employing the trypan blue assay for cell viability [32].
Three major classes of proteases are involved in cell death and
these are the caspases, the calpains and the lysosomal cathepsins.
Out of these classes both caspases and calpains are cysteine
proteases while the lysosomal cathepsins are serine, aspartyl, as
well as cysteine proteases. We chose to use three different protease
inhibitors ‘‘specific’’ to the different types of cell death. z-VAD-
Figure 4. Effect of 16 hours Oxygen-Glucose Deprivation (OGD) on % survival of PC12 cells in the absence or presence of different
combinations of caspase, calpain and aspartyl protease inhibition (10 mM/10 mM/5 mM). The values are presented as mean 6 SEM,
*p,0.05, **p,0.01. Panel a, naive PC12 cells, panel b PC12 cells NGF treated.
doi:10.1371/journal.pone.0025950.g004
Role of Aspartyl Proteases on Hypoxic PC12 Cells
PLoS ONE | www.plosone.org 5 October 2011 | Volume 6 | Issue 10 | e25950fmk, MDL28170 and pepstatin A. Since inhibition of protease
activity is of the outmost importance pertaining to the design of
this work we took great care to ensure that each protease inhibitor
is specific to each class of proteases involved. Information about
the specificity of protease inhibitors employed was primarily from
the MEROPS Database [33]. z-VAD-fmk is a specific inhibitor of
caspases (cysteine proteases central to the apoptotic mechanism).
We stress out the fact that at 10 mM concentration used herein, z-
VAD-fmk is a caspase-specific inhibitor, while at higher concen-
trations (50–100 mM) it can also abolish the activity of the
cathepsins (cysteine lysosomal proteases B and L) [34]. MDL28170
was used as a specific inhibitor of calpains (calcium dependent
cysteine proteases involved in necrotic cell death) that can also
inhibit the lysosomal cysteine protease cathepsin B, albeit to a
lesser extent and with lower affinity for it (Ki values are 10 and
25 nM, respectively), [35,36]. Lastly, pepstatin A was used as a
specific inhibitor for aspartyl proteases including the lysosomal
aspartyl proteases cathepsins D and E [34].
Our data show that inhibition of the caspase activity with
10 mM z-VAD-fmk rescues PC12 cells from OGD induced
apoptosis (Figure 1a). Higher concentrations of the inhibitor
were not as effective in protecting the cells. Similarly, inhibition of
the calpains by 10 mMo r5 0mM MDL28170 rescues PC12 cells
from OGD elicited cell death (Figure 2a). Similar results were
obtained when using the same inhibitors with PC12 cells
differentiated with NGF indicating that the cell death or survival
mechanism was passed into the differentiated phenotype
(Figures 1b and 2b). Since we find that both inhibitors rescue
the cells from OGD elicited cell death indicates that i) both
apoptosis and necrosis are two individual and separate compo-
nents of the OGD elicited cell death or ii) both apoptosis and
necrosis share components of their machinery to one another. In
fact the latter hypothesis is supported by the results from the
experiments employing combinations of the inhibitors used
(figures 4a and 4b). This is also supported by other reports. For
example the calpain-cathepsin hypothesis in which calpain
mediated lysosomal rupture and release of cathepsin B initiates
necrosis [37,38]. Additionally, other reports suggest that cathepsin
B is required for the initiation of apoptosis [23,24,39]. When we
used pepstatin A as a specific inhibitor of cathepsins D and E,
alone or in combination, with the other inhibitors we observed
protection from OGD in all cases (Figures 3a, 4a). The same
results were obtained with the NGF differentiated PC12 cells
(Figures 3b and 4b).
Using flow cytometry we were not able to detect any protection
from OGD on naive or NGF treated PC12 cells applying caspase
or calpain inhibitors, alone or in combinations to each other
(Figures 5a,b,d and 6a,b,d). When pepstatin A was used to
protect from proteolysis, alone or in combinations with the other
inhibitors, we were able to demonstrate protection from OGD and
this was observed both on naive PC12 and NGF treated cells
(Figures 5 c,e,f,g and 6 c,e,f,g). Inhibition with pepstatin A
lowered the percentages of the dead and apoptotic cell population
and raised the percentage of the living cells.
We argue that the failure to detect any protection while using
apoptosis or necrosis specific inhibitors is relevant to the extent of
Figure 5. Effect of 16 hours Oxygen-Glucose Deprivation
(OGD) on naive PC12 cells tested with Annexin V–FITC/PI cell
membrane permeability assay after caspase (10 mM), calpain
(10 mM), aspartyl protease (5 mM) inhibition, and their combi-
nations panels a to g. The values are presented as mean 6 SEM,
*p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0025950.g005
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inhibition of aspartyl proteases provided significant protection of
PC12 exposed to OGD in all cases we propose that the lysosomal
cathepsins D and E may have a distinct role in the cell death
elicited by OGD.
This role is central both on naive and NGF treated PC12 cells
indicating that the mechanism(s) involved are conserved through
the NGf induced differentiation process.
The role of the aspartyl proteases and in particular of cathepsin
D in the different cell death pathways has been subject for intense
investigation. Cathepsin D is reported to promote or to even to
inhibit apoptosis in certain cases, while in others, it promotes
necrosis [25,40,41]. Thus, until now, the role of cathepsin D
remains controversial.
Autophagy is currently emerging as a third way of controlled
cell death. Autophagy is a highly organised cellular process aiming
mainly in the recycling of misfolded or aged proteins or protein
aggregates. The pathway evolved in unicellular eukaryotes as
means to conserve energy in times of food shortage. There are
different subclasses of autophagy such as macroautophagy,
microautophagy and chaperon-mediated macroautophagy. In all
cases the cellular parts or protein aggregates are driven into the
lysosome for degradation. The pathway of autophagy has been
implicated in many neurodegenerative diseases [42] and the
interplay of autophagy with the established mechanisms of cell
death i.e. apoptosis and necrosis is now apparent [27]. There are
even recent reports stating that autophagy is involved in ischemic
preconditioning [8].
As is evident from the above, approaches to understand the
response of PC12 cells to OGD by means of proteolysis inhibition
are extremely complex. Not only calpain mediated necrosis leads
to lysosome rupture and release of cathepsin B but also apoptosis
seems to be regulated by the cathepsin B as well. One the other
hand our approach removes the magnifying glass of the scientist
and takes a peek to a bigger picture pertaining to the participation
of each class of proteases tested to the cell death elicited by OGD.
Our data shows that mobilisation of caspases or calpains have
limited effect in the death induced by OGD and indicate a distinct
role for the lysosomal aspartyl cathepsins D and E. We propose
that in view of the recent advances in the field of protein turn over
and degradation future research should focus towards understand-
ing the role of aspartyl proteases in OGD elicited cell death.
Materials and Methods
Cell cultures
All experiments were performed with rat pheochromocytoma
(PC12) cells a generous gift from I. Papamatheakis (Institute of
Molecular Biology and Biotechnology, Foundation of Research
and Technology Heraklion Crete, Greece). Naive PC12 cells were
cultured in collagen-coated dishes with High Glucose Dulbecco’s
Modified Eagle Medium (DMEM 4.5 g/l glucose) (Gibco)
supplemented with 2.5% heat-inactivated foetal bovine serum
(Gibco), 15% heat-inactivated horse serum (Gibco) 100 U/ml
penicillin and 100 mg/ml streptomycin, in vented culture flasks
(BD). The cultures were maintained in 5% CO2–95% humidified
air at 37uC. Medium was changed every 2–3 days. By 3 to 4 days
Figure 6. Effect of 16 hours Oxygen-Glucose Deprivation
(OGD) on NGF treated PC12 cells, tested with Annexin V–
FITC/PI cell membrane permeability assay, after caspase
(10 mM), calpain (10 mM), aspartyl protease (5 mM) inhibition
and their combinations. Panels a to g. The values are presented as
mean 6 SEM, *p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0025950.g006
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and were seeded onto a 96-well flat bottom microtitre plate at a
cell density of 1610
5/well for testing [43,44].
Cell viability
Routine assessment of cell viability was determined using the
trypan blue exclusion assay. Living cells (not stained by trypan
blue, Sigma) were counted on a Neubauer plate.
NGF Differentiation
PC12 cells were seeded in 96-well plates (corning) at a density of
10
5 cells/well, in low glucose medium (DMEM 1000 mg/ml
glucose) with 100 ng/ml rat recombinant 2.5S NGF (R&D).
Medium and NGF were replenished every 2–3 days. Experiments
were performed after 7–8 days of NGF-induced differentiation. All
conditions were performed in triplicates. Medium changes were
performed at least 24 h before any experiments in NGF-treated
cells, to ensure that a basal state of signalling had been reached.
Lethal Hypoxia-OGD
Lethal hypoxia was induced by exposing PC12 cultures to a
calibrated gas mixture of 2%CO2,5 %C O 2, 93% N2 in a 3-gas
incubator (Forma Scientific), in complete medium (DMEM)
depleted of glucose and sodium pyruvate, for 16 hours, according
to protocols described by [8,45]. Control cells were maintained in
normoxia (5% CO2–95% humidified air), in complete low glucose
medium (DMEM 1,0 g/l).
MTT assay
Integrity of cellular function was measured by the MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; Sigma-Al-
drich) tetrazolium salt assay. This colorimetric assay is based on
the capacity of the mitochondrial enzyme succinate dehydroge-
nase to reduce the yellow MTT tetrazolium salt into blue MTT
formazan crystals by living cells. The level of conversion provides
an indication of mitochondrial metabolic function. MTT,
according to the manufacturer’s instructions, was dissolved in
DMEM without phenol red at a final concentration of 5 mg/ml,
and served as a stock solution. PC12 cells exposed to OGD were
further incubated for 4 h with 1 mg/ml MTT at 37uCi na
normoxic chamber. At the end of the incubation period MTT
formazan crystals were solubilised with 0.1 N HCl isopropanol
and absorption was detected at 570 nm, with background
subtraction at 630 nm, using a micro-plate reader (Stat Fax –
2100, Awareness Technology Inc. USA) [43,44,46].
Flow cytometry
To detect the translocation of phosphatidylserine from the inner
face of the cell membrane to the outer surface, we used the
Annexin V–FITC cell membrane labelling assay as an early
marker of apoptosis. In order to label the DNA in cells where the
cell membrane had been compromised we used Propidium iodide
(PI). The assay was performed using an Annexin V–FITC
Apoptosis Detection Kit according to the manufacturer’s instruc-
tions (BD).
Cells were collected, washed in PBS and re-suspended in
binding buffer and a 0.5 ml aliquot was withdrawn for analysis.
After addition of Annexin V–FITC and PI, the sample was
incubated for 10 min in the dark. Stained cells were analysed on a
BD flow cytometer, excitation was at 488 nm and green and red
emission filters were at 515–545 nm and 600 nm respectively. A
total of 10,000 cells were counted per sample, and the data were
processed using standard software.
Routinely, the MTT and the Annexin V-FITC/PI staining
assays for flow cytometry were performed in parallel in twin
cultures that were subjected to identical conditions. This
procedure was adopted in order to eliminate variations of the
cell population, growth conditions and experimental procedures.
Inhibitors
Caspase activity following oxygen and glucose deprivation was
tested using zVAD-fmk (N-benzyloxycarbonyl-Val-Ala-Asp-fluor-
omethylketone - Sigma), a cell permeable, irreversible caspase
inhibitor. zVAD-fmk was prepared as 5006stocks in dimethylsulf-
oxide and applied at 10 mM and 50 mM concentrations to PC12
and NGF treated cells 30 min before oxygen and glucose
deprivation treatment.
We tested also the effects of a calpain inhibitor MDL28170
(Cbz-Val-Phe-CHO - Sigma) after oxygen and glucose depriva-
tion. The compound, MDL28170, is a membrane-permeable
cysteine protease inhibitor which potently inhibits both calpain I
and II. MDL28170 was made as 5006stock solution in
dimethylsulfoxide and applied at 10 mM, 50 mM and 100 mM
concentrations 30 min before OGD treatment.
Aspartyl-protease involvement in cell damage by OGD was
investigated using pepstatin A, a lysosomal aspartic protease
inhibitor. Pepstatin A (Sigma) was prepared as 1 mg/ml in 10%
(v/v) acetic acid in methanol (9:1 methanol: acetic acid), and
applied at 1 mM and 5 mM concentrations to PC12 and NGF
treated cells 30 min before oxygen and glucose deprivation
treatment.
Statistical analysis
The computer software SPSS 16.0 (SPSS Inc.) was used for all
statistical calculations and analyses. All data were analyzed with
analysis of variance (ANOVA) for repeated measurements. If
significant, ANOVA was followed by post hoc multiple compar-
isons with CTRL and ND group by Dunett’s test. Two-tailed
levels of significance were used in all statistical calculations.
Statistical significance level for group differences was set at
P#0.05. All data are expressed as mean 6 standard error of the
mean (SEM) of separate experiments n$3. Significant differences
were indicated by *p=0.05, **p=0.01 and ***p=0.001 with
respect to control or a corresponding single treatment.
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